Advarra, a provider of institutional review board, institutional biosafety committee and research technology solutions, completed the acquisition of IRBco, a provider of staffing solutions. Financial terms were not disclosed. "Advarra builds on its commitment to advance human health and better enable clinical trials with this acquisition. IRBco studies will be fully integrated with Advarra in a matter of weeks, and we look forward to the additional talent and board expertise this will bring to our organization. We will maintain our focus on developing altogether better capabilities that serve clients and protect research participants," Gadi Saarony, Advarra CEO.